Inventor · disambiguated record
Jong Soo Woo
Also filed as: WOO JONG H · WOO JONG S · WOO JONG SOO
37 granted patents·43 pending applications·587 citations·filing 1994–2021
97Inventor score
Top patents by PatentIndex Score
80 records- 0193US8127516B2Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the sameLEE CHANG HYUN·Filed 2009·Granted Mar 6, 2012·40 cites·16 claims
- 0292US5589455ACyclosporin-containing soft capsule compositionsHANMI PHARM IND CO LTD·Filed 1995·Granted Dec 31, 1996·156 cites·14 claims
- 0390US9220704B2Composite formulation comprising a tablet encapsulated in a hard capsuleHANMI PHARM IND CO LTD·Filed 2012·Granted Dec 29, 2015·7 cites·11 claims
- 0487US6039981AAntifungal oral composition containing itraconazole and process for preparing sameHANMI PHARM IND CO LTD·Filed 1999·Granted Mar 21, 2000·82 cites·5 claims
- 0585US5639474ACyclosporin soft capsule compositionHANMI PHARM IND LTD·Filed 1995·Granted Jun 17, 1997·84 cites·10 claims
- 0679US9931406B2Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricantHANMI PHARM IND CO LTD·Filed 2017·Granted Apr 3, 2018·2 cites·18 claims
- 0779US5603951ACyclosporin-containing soft capsule compositionsHANMI PHARM IND CO LTD·Filed 1995·Granted Feb 18, 1997·52 cites·19 claims
- 0877US9283218B2Solid dispersion with improved solubility comprising tetrazole derivative as an active ingredientHANMI PHARM IND CO LTD·Filed 2013·Granted Mar 15, 2016·3 cites·20 claims
- 0977US5958876ACyclosporin-containing pharmaceutical compositionsNOVARTIS AG·Filed 1998·Granted Sep 28, 1999·46 cites·24 claims
- 1073US9731022B2Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricantKIM YONG IL·Filed 2012·Granted Aug 15, 2017·2 cites·23 claims
- 1173US6936625B2Amlodipine camsylate and method for preparing thereofHANMI PHARM IND CO LTD·Filed 2002·Granted Aug 30, 2005·6 cites·8 claims
- 1272US9867801B2Amorphous solid dispersion comprising taxane, tablet comprising the same, and method for preparing the sameHANMI PHARM IND CO LTD·Filed 2015·Granted Jan 16, 2018·2 cites·33 claims
- 1365US5803988AMethod for manufacturing non-oriented electrical steel sheet showing superior adherence of insulating coated layerPO HANG IRON & STEEL·Filed 1996·Granted Sep 8, 1998·24 cites·4 claims
- 1464US6428821B2Oral micro-emulsion composition of silybinFiled 2001·Granted Aug 6, 2002·4 cites·5 claims
- 1563US8673945B2Solid pharmaceutical composition comprising amlodipine and losartanWOO JONG SOO·Filed 2009·Granted Mar 18, 2014·0 cites·7 claims
- 1662US5653821AMethod for manufacturing oriented electrical steel sheet by heating slab at low temperaturePO HANG IRON & STEEL·Filed 1994·Granted Aug 5, 1997·24 cites·12 claims
- 1761US2004151773A1Enteric coated formulation of a benzimidazole derivative and method for preparation thereofFiled 2004·Application pending·0 cites
- 1860US6451128B1Method for manufacturing high magnetic flux denshy grain oriented electrical steel sheet based on low temperature slab heating methodPO HANG IRON & STEEL·Filed 1998·Granted Sep 17, 2002·14 cites·22 claims
- 1960US2021154180A1Formulation having improved ph-dependent drug-release characteristics containing esomeprazole or pharmaceutically acceptable salt thereofHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 2059US6107290ANon-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereofHAMMI PHARM CO LTD·Filed 1999·Granted Aug 22, 2000·25 cites·10 claims
- 2158US10946003B2Formulation having improved pH-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereofHANMI PHARM IND CO LTD·Filed 2017·Granted Mar 16, 2021·0 cites·6 claims
- 2258US2021330666A1Oral solid formulation containing irinotecan and method of preparing the sameHANMI PHARM IND CO LTD·Filed 2021·Application pending·0 cites
- 2357US9283232B2Dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromide, and method for preparing sameHANMI PHARM IND CO LTD·Filed 2013·Granted Mar 15, 2016·0 cites·8 claims
- 2454US7759368B2Sustained release composition for oral administration of niacinHANMI PHARM IND CO LTD·Filed 2005·Granted Jul 20, 2010·0 cites·5 claims
- 2554US2006078619A1Method for the preparatin of paclitaxel solid dispersion by using the supercritical fluid process and paclitaxel solid dispersion prepared therebyHANMI PHARM IND CO LTD·Filed 2003·Application pending·0 cites
- 2654US2010233261A1Pharmaceutical Composition Comprising Amlodipine and LosartanHANMI PHARM IND CO LTD·Filed 2007·Application pending·0 cites
- 2753US11090299B2Oral solid formulation containing irinotecan and method of preparing the sameHANMI PHARM IND CO LTD·Filed 2016·Granted Aug 17, 2021·0 cites·8 claims
- 2851US9801876B2Complex granule formulation having improved stability comprising levocetirizine and montelukastHANMI PHARM IND CO LTD·Filed 2014·Granted Oct 31, 2017·0 cites·8 claims
- 2951US2008292702A1Solid Dispersion Comprising An Active Ingredient Having A Low Melting Point And Tablet For Oral Administration Comprising SameHANMI PHARM IND CO LTD·Filed 2006·Application pending·0 cites
- 3050US6706285B1Enteric coated formulation of a benzimidazole derivative and method for preparation thereofHANMS PHARM CO LTD·Filed 1999·Granted Mar 16, 2004·12 cites·2 claims
- 3150US2005058670A1Oral itraconazole composition which is not affected by ingested food and process for preparing sameFiled 2003·Application pending·0 cites
- 3250US2003185886A1Process for the preparation of rapidly disintegrating tabletHANMI PHARM IND CO LTD·Filed 2003·Application pending·0 cites
- 3349US9486528B2Stable pharmaceutical formulation for oral administration comprising levocetirizine or a pharmaceutically acceptable salt thereof, and montelukast or a pharmaceutically acceptable salt thereofHANMI PHARM IND CO LTD·Filed 2013·Granted Nov 8, 2016·0 cites·10 claims
- 3449US7485326B2Oral microemulsion composition comprising biphenyldimethyldicarboxylate and silybinHANMI PHARM IND CO LTD·Filed 2004·Granted Feb 3, 2009·0 cites·8 claims
- 3549US7282102B2Method for manufacturing high silicon grain-oriented electrical steel sheet with superior core loss propertyPOSCO·Filed 2003·Granted Oct 16, 2007·1 cites·8 claims
- 3648US7435304B2Coating composition, and method for manufacturing high silicon electrical steel sheet using thereofPOSCO·Filed 2003·Granted Oct 14, 2008·1 cites·26 claims
- 3748US2014314844A1Oral complex formulation comprising omega-3 fatty acid and hmg-coa reductase inhibitor with improved stabilityHANMI PHARM IND CO LTD·Filed 2012·Application pending·0 cites
- 3847US10434067B2Composite formulation for oral administration comprising ezetimibe and rosuvastatinHANMI PHARM IND CO LTD·Filed 2014·Granted Oct 8, 2019·0 cites·10 claims
- 3947US2002049158A1Oral drug composition containing a verapamil derivative as a drug-absorption promotorFiled 2001·Application pending·0 cites
- 4046US9549936B2Method for preparing dry powder for inhalation formulation comprising salmeterol xinafoate, fluticasone propionate and tiotropium bromideHANMI PHARM IND CO LTD·Filed 2015·Granted Jan 24, 2017·0 cites·5 claims
- 4146US2012110957A1Method for preparing rapidly disintegrating formulation for oral administrationLEE CHANG HYUN·Filed 2012·Application pending·0 cites
- 4246US2008096866A1Complex Formulation Of 3-Hydroxy-3-Methyl Glutaryl Coa Reductace Inhibitor And Antihypertensive Agent, And Process For Preparing SameHANMI PHARM IND CO LTD·Filed 2005·Application pending·0 cites
- 4346US2010048511A1Complex formulation for preventing or treating osteoporosis which comprises solid dispersion of vitamin d or its derivative and bisphosphonateHANMI PHARM IND CO LTD·Filed 2007·Application pending·0 cites
- 4445US2013243872A1Pharmaceutical composite formulation comprising hmg-coa reductase inhibitor and aspirinKIM YONG IL·Filed 2011·Application pending·0 cites
- 4545US2016263040A1Composite formulation comprising tadalafil and amlodipineHANMI PHARM IND CO LTD·Filed 2014·Application pending·0 cites
- 4644US2015231085A1Pharmaceutical composite capsule formulation comprising irbesartan and hmg-coa reductase inhibitorHANMI PHARM IND CO LTD·Filed 2013·Application pending·0 cites
- 4744US2015209290A1Bilayered composite tablet formulation comprising atorvastatin, irbesartan and magnesium carbonateHANMI PHARM IND CO LTD·Filed 2013·Application pending·0 cites
- 4843US2021322319A1A pharmaceutical formulation for oral administration with improved content uniformity comprising sustained-release pellets containing tamsulosin hydrochlorideHANMI PHARM IND CO LTD·Filed 2017·Application pending·0 cites
- 4943US2009175952A1Cefuroxime axetil granule and process for the preparation thereofWOO JONG SOO·Filed 2005·Application pending·0 cites
- 5043US2014170213A1Capsule formulation comprising montelukast and levocetirizineKIM YONG II·Filed 2012·Application pending·0 cites
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jong Soo Woo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →